Endogenous endothelin-1 initiates astrocytic growth after spinal cord injury

Brain Research

Volumn 728, Issue 2, 1996, Pages 255-259

  Uesugi, Masafumi ^a   Kasuya, Yoshitoshi ^a   Hama, Hiroshi ^a   Yamamoto, Miyuki ^a   Hayashi, Kohichiroh ^a   Masaki, Tomoh ^b   Goto, Katsutoshi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Astrocyte; Endothelin 1; Monoclonal antibody RC1; SB209670; Spinal cord injury

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INTRATHECAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY;

EID: 0030605824     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00524-0     Document Type: Article

References (22)

1. [1] Culican, S.M., Baumrind, N.L., Yamamoto, M. and Pearlman, A.L., Cortical radial glia: identification in tissue culture and evidence for their transformation to astrocytes, J. Neurosci., 10 (1990) 684-692.
2. [2] Edwards, M.A., Yamamoto, M. and Caviness Jr., V.S., Organization of radial glia and related cells in the developing murine CNS. An analysis based upon a new monoclonal antibody marker, Neuroscience, 36 (1990) 121-144.
3. [3] Garrison, C.J., Daugherty, P.M., Kajander, K.C. and Carlton, S.M., Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury, Brain Res., 565 (1991) 1-7.
4. B receptor, Biochem. Biophys. Res. Commun., 186 (1992) 355-362.
5. [5] Hori, S., Komatsu, Y., Shigemoto, R., Mizuno, N. and Nakanishi, S., Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors, Endocrinology, 130 (1992) 1885-1895.
6. [6] Hösli, H. and Hösli, L., Autoradiographic evidence for endothelin receptors on astrocytes in cultures of rat cerebellum, brainstem and spinal cord, Neurosci. Lett., 129 (1991) 55-58.
7. [7] Iwata, R., Ito, H., Hayashi, T., Sekine, Y., Koyama, N. and Yamaki, M., Stable and general-purpose chemiluminescent detection system for horseradish peroxidase employing a thiazole compound enhancer and some additives, Anal. Biochem., 231 (1995) 170-174.
8. [8] Kasuya, Y., Abe, Y., Hama, H., Sakurai, T., Asada, S., Masaki, T. and Goto, K., Endothelin-1 activates mitogen-activated protein kinases through two independent signalling pathways in rat astrocytes, Biochem. Biophys. Res. Commun., 204 (1995) 1325-1333.
9. [9] Kitamura, T., Dynamic aspects of glial reactions in altered brains, Pathol. Res. Pract., 168 (1980) 301-343.
10. [10] MacCumber, M.W., Ross, C.A. and Snyder, S., Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells, Proc. Natl. Acad. Sci. USA, 87 (1990) 2359-2363.
11. [11] Masaki, T., Yanagisawa, M. and Goto, K., Physiology and pharmacology of endothelins, Med. Res. Rev., 12 (1992) 391-421.
12. [12] O'Brien, M.F., Lenke, L.G., Lou, J., Bridwell, K.H. and Joyce, M.E., Astrocyte response and transforming growth factor-beta localization in acute spinal cord injury, Spine, 19 (1994) 2321-2330.
13. [13] O'Callagham, J.P., Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarker, Biomed. Environ. Sci., 4 (1991) 197-206.
14. [14] Olstein, E.H., Nambi, P., Douglas, S.A., Edwards, R.M., Gellai, M., Lago, A., Leber, J.D., Cousins, R.D., Gao, A., Franzee, J.S., Peishoff, C.E., Bean, J.W., Eggleston, D.S., Elshourbagy, N.A., Kumar, C., Lee, J.A., Yue, T.-L., Louden, C., Brooks, D.P., Weinstock, J., Feuerstein, G., Poste, G., Ruffolo, Jr. R.R., Gleason, J.G. and Elliott, J.D., SB209670, a rationally designed potent nonpeptide endothelin receptor antagonist, Proc. Natl. Acad. Sci. USA, 91 (1994) 8052-8056.
15. [15] Rudge, J.S., Astrocyte-derived neurotrophic factors. In S. Murphy (Ed.), Astrocytes: Pharmacology and Function, Academic Press, San Diego, 1993, pp. 267-305.
16. [16] Sakurai, T., Yanagisawa, M. and Masaki, T., Molecular characterization of endothelin receptors, Trends Pharmacol Sci., 13 (1992) 103-108.
17. [17] Suzuki, N., Matsumoto, H., Miyauchi, T., Kitada, C., Tsuda, M., Goto, K., Masaki, T. and Fujino, M., Sandwich-enzyme immunoassays for endothelin family peptides, J. Cardiovasc. Pharmacol., 17 (Suppl.7) (1991) S420-S422.
18. [18] Takamiya, Y., Kohsaka, S., Toya, S., Otani, M. and Tsukada, Y., Immunochemical studies on the proliferation of reactive astrocytes and the expression of cytoskeltal proteins following brain injury in rats, Brain Res., 466 (1988) 201-210.
19. [19] Williams, L.D., Jones, L.K., Pettibone, J.D., Lis, V.E. and Clineschmidt, B.V., Sarafotoxin S6C: an agonist which distinguishes between endothelin receptor subtypes, Biochem. Biophys. Res. Commun., 175 (1991) 556-561.
20. [20] Yamada, G., Hama, H., Kasuya, Y., Masaki, T. and Goto, K., Possible sources of endothelin-1 in damaged rat brain, J. Cardiovasc. Pharmacol., 26 (Suppl. 3) (1995) S448-S451.
21. B receptor aggregate in rat hippocampus CA1 subfields following transient forebrain ischemia, J. Neurochem., 63 (1994) 1042-1051.
22. [22] Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, M., Yazaki, Y., Goto, K. and Masaki, T., A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature, 332 (1988) 411-415.